LAHORE GENERAL HOSPITAL
🇵🇰Pakistan
Clinical Trials
16
Active:4
Completed:4
Trial Phases
4 Phases
Early Phase 1:2
Phase 1:1
Phase 2:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Not Applicable
8 (66.7%)Early Phase 1
2 (16.7%)Phase 1
1 (8.3%)Phase 2
1 (8.3%)Effect of Platelet-Rich Plasma on Graft Uptake and Postoperative Outcomes in Full-Thickness Skin Grafting of Face and Neck
Not Applicable
- Conditions
- Skin TransplantationReconstructive Surgical Procedures
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- Lahore General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT07112898
- Locations
- 🇵🇰
Lahore General Hospital, Lahore, Lahore, Punjab, Pakistan
Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo
Not Applicable
Active, not recruiting
- Conditions
- Vitiligo
- Interventions
- First Posted Date
- 2025-06-29
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- Lahore General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT07044141
- Locations
- 🇵🇰
Lahore general.hospital, Lahore, Punjab, Pakistan
Comparison of Once-Weekly Trelagliptin Vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 Diabetes
Not Applicable
Active, not recruiting
- Conditions
- Type 2 Diabetes Mellitus (T2DM)
- Interventions
- First Posted Date
- 2025-03-21
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Lahore General Hospital
- Target Recruit Count
- 102
- Registration Number
- NCT06889909
- Locations
- 🇵🇰
Lahore General Hospital, Lahore, Lahore, Punjab, Pakistan
Role of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver Failure
Not Applicable
Active, not recruiting
- Conditions
- Acute Liver FailureDrug-Induced Liver Injury
- Interventions
- Other: Standard supportive care
- First Posted Date
- 2025-03-12
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Lahore General Hospital
- Target Recruit Count
- 62
- Registration Number
- NCT06872372
- Locations
- 🇵🇰
Lahore General Hospital, Lahore, Lahore, Punjab, Pakistan
Effect of Melatonin on Schizophrenic Symptoms: a Randomized Placebo-Controlled Trial
Not Applicable
Active, not recruiting
- Conditions
- Schizophrenia DisordersPsychotic Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-02-20
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Lahore General Hospital
- Target Recruit Count
- 76
- Registration Number
- NCT06838104
- Locations
- 🇵🇰
Lahore General Hospital, Lahore, Lahore, Punjab, Pakistan
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found